The chemical substance with the name "(5S)-5-(methoxymethyl)-3-[6-(4,4,4-trifluorobutoxy)-1,2-benzoxazol-3-yl]-1,3-oxazolidin-2-one" and CAS number "185835-97-6" is characterized by its complex molecular structure, which includes an oxazolidinone core, a benzoxazole moiety, and a trifluorobutoxy substituent. This compound is likely to exhibit specific stereochemistry due to the presence of the (5S) configuration, which can influence its biological activity and interactions. The methoxymethyl group may enhance solubility and stability, while the trifluorobutoxy group could impart unique electronic properties, potentially affecting its reactivity and pharmacological profile. Such compounds are often studied for their potential applications in medicinal chemistry, particularly as antimicrobial or anticancer agents. The presence of fluorine atoms typically enhances lipophilicity and metabolic stability, making these compounds of interest in drug development. Overall, the unique combination of functional groups and structural features suggests that this substance may possess interesting biological activities warranting further investigation.

(5S)-5-(METHOXYMETHYL)-3-[6-(4,4,4-TRIFLUOROBUTOXY)-1,2-BENZOXAZOL-3-YL]-1,3-OXAZOLIDIN-2-ONE

185835-97-6: The chemical substance with the name "(5S)-5-(methoxymethyl)-3-[6-(4,4,4-trifluorobutoxy)-1,2-benzoxazol-3-yl]-1,3-oxazolidin-2-one" and CAS number "185835-97-6" is characterized by its complex molecular structure, which includes an oxazolidinone core, a benzoxazole moiety, and a trifluorobutoxy substituent. This compound is likely to exhibit specific stereochemistry due to the presence of the (5S) configuration, which can influence its biological activity and interactions. The methoxymethyl group may enhance solubility and stability, while the trifluorobutoxy group could impart unique electronic properties, potentially affecting its reactivity and pharmacological profile. Such compounds are often studied for their potential applications in medicinal chemistry, particularly as antimicrobial or anticancer agents. The presence of fluorine atoms typically enhances lipophilicity and metabolic stability, making these compounds of interest in drug development. Overall, the unique combination of functional groups and structural features suggests that this substance may possess interesting biological activities warranting further investigation.

(5S)-5-(methoxymethyl)-3-[6-(4,4,4-trifluorobutoxy)-1,2-benzoxazol-3-yl]-1,3-oxazolidin-2-one

<p>SL-25.1188: Reversible MAO-B inhibitor with high brain uptake &amp; slow plasma metabolism.</p>

CAS 185835-97-6

(5S)-5-(METHOXYMETHYL)-3-[6-(4,4,4-TRIFLUOROBUTOXY)-1,2-BENZOXAZOL-3-YL]-1,3-OXAZOLIDIN-2-ONE

(5S)-5-(methoxymethyl)-3-[6-(4,4,4-trifluorobutoxy)-1,2-benzoxazol-3-yl]-1,3-oxazolidin-2-one

Ref: IN-DA00387U

SL-25.1188

Ref: TM-T28798